Natural peptide revealed anti-tumor activity ALCL mouse models

Researchers at MedUni Vienna, Karl Landsteiner University of Health Sciences, University of Veterinary Medicine Vienna and Ludwig Boltzmann Institute for Cancer Research demonstrate an anti-tumor effect of certain nature-derived cyclic peptides.

Link to the news feed of the Medical University of Vienna.

The publication is online available : Biomedicine & Pharmacotherapy
J. Lind, R. Hellinger, P. Kudweis, H. P. Moll, J. Gattringer, K. Thell, S. Edtmayer, C. W. Gruber, D. Stoiber, K. Kollmann.
The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma
DOI: https://doi.org/10.1016/j.biopha.2022.113486

36th European Peptide Symposium

The research consortium presented their recent work with three poster and one oral presentation on the 36th European Peptide Symposium in Sitges, Spain. Jasmin Gattringer talked on her project „Cyclic peptides as modulators of immune cell migration“ as invited speaker for the Young Investigator Mini Symposium. Paula Schwarz, Kirtikumar Jadhav and Roland Hellinger presented posters. EPS

« Ältere Einträge Letzte Einträge »